Nicola d’Avanzo

721 total citations · 1 hit paper
24 papers, 533 citations indexed

About

Nicola d’Avanzo is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Nicola d’Avanzo has authored 24 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Biomaterials and 8 papers in Biomedical Engineering. Recurrent topics in Nicola d’Avanzo's work include Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Nicola d’Avanzo is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Nicola d’Avanzo collaborates with scholars based in Italy, Lithuania and China. Nicola d’Avanzo's co-authors include Massimo Fresta, Christian Celia, Donatella Paolino, Maria Chiara Cristiano, Antonia Mancuso, Luisa Di Marzio, Hélder A. Santos, Antonella Barone, Joy Wolfram and Martina Di Francesco and has published in prestigious journals such as ACS Nano, Molecules and International Journal of Pharmaceutics.

In The Last Decade

Nicola d’Avanzo

23 papers receiving 524 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis

2022 106 citations Maria Chiara Cristiano, Christian Celia et al. ACS Nano profile →

Peers

Countries citing papers authored by Nicola d’Avanzo

Since Specialization

Citations

This map shows the geographic impact of Nicola d’Avanzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola d’Avanzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola d’Avanzo more than expected).

Fields of papers citing papers by Nicola d’Avanzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola d’Avanzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola d’Avanzo. The network helps show where Nicola d’Avanzo may publish in the future.

Co-authorship network of co-authors of Nicola d’Avanzo

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola d’Avanzo. A scholar is included among the top collaborators of Nicola d’Avanzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola d’Avanzo. Nicola d’Avanzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing effectiveness of multistage nanomedicines for multidrug therapy of vitiligo 2025 ·Journal of Drug Delivery Science and Technology ·Antonia Mancuso, Maria Chiara Cristiano, Nicola d’Avanzo, Salvatore Panza, (unknown), Christian Celia, Donatella Paolino, Massimo Fresta	2
2	Microfluidic Design of Ultradeformable Liposomes for Advanced Skin Delivery of Stellaria media Phytocomplex 2025 ·Pharmaceutics ·(unknown), Nicola d’Avanzo, Antonia Mancuso, Maria Chiara Cristiano, Antonella Barone, Rosario Mare, Anna Maria Tolomeo, (unknown), Georgiana Nițulescu, Octavian Tudorel Olaru, Felisa Cilurzo, Donatella Paolino, Massimo Fresta	0
3	Unraveling the impact of different liposomal formulations on the plasma protein corona composition might give hints on the targeting capability of nanoparticles 2024 ·Nanoscale Advances ·Esther Imperlini, Luisa Di Marzio, Armando Cevenini, Michele Costanzo, Nicola d’Avanzo, Massimo Fresta, Stefania Orrù, Christian Celia, Francesco Salvatore	2
4	Improved anti-breast cancer activity by doxorubicin-loaded super stealth liposomes 2024 ·Biomaterials Science ·(unknown), Nicola d’Avanzo, (unknown), (unknown), Antonella Grigoletto, Maria Chiara Cristiano, Antonia Mancuso, Christian Celia, Gianfranco Pasut, Massimo Fresta	5
5	OX26-cojugated gangliosilated liposomes to improve the post-ischemic therapeutic effect of CDP-choline 2024 ·Drug Delivery and Translational Research ·Nicola d’Avanzo, Donatella Paolino, Antonella Barone, (unknown), Antonia Mancuso, (unknown), Anna Maria Tolomeo, Christian Celia, Xiaoyong Deng, Massimo Fresta	9
6	Antimicrobial Compounds from Food Waste in Cosmetics 2024 ·Cosmetics ·(unknown), Antonia Mancuso, Nicola d’Avanzo, Maria Chiara Cristiano, Donatella Paolino	7
7	Olive Leaves and Citrus Peels: From Waste to Potential Resource for Cosmetic Products 2024 ·Cosmetics ·Nicola d’Avanzo, Antonia Mancuso, Rosario Mare, (unknown), Samantha Maurotti, Ortensia Ilaria Parisi, Maria Chiara Cristiano, Donatella Paolino	13
8	Skin Tolerability of Oleic Acid Based Nanovesicles Designed for the Improvement of Icariin and Naproxen Percutaneous Permeation 2024 ·ACS Applied Bio Materials ·Shabir Ahmad, Nicola d’Avanzo, Antonia Mancuso, Antonella Barone, Maria Chiara Cristiano, Cristina Carresi, Vincenzo Mollace, Christian Celia, Massimo Fresta, Donatella Paolino	2
9	Thermoresponsive M1 macrophage-derived hybrid nanovesicles for improved in vivo tumor targeting 2023 ·Drug Delivery and Translational Research ·Antonella Barone, (unknown), Nicola d’Avanzo, Anna Maria Tolomeo, Stefano Ruga, Antonio Cardamone, Christian Celia, Mariangela Scalise, Daniele Torella, Massimo La Deda, Enrico Iaccino, Donatella Paolino	14
10	Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models 2023 ·Drug Resistance Updates ·Vilma Petrikaitė, Nicola d’Avanzo, Christian Celia, Massimo Fresta	18
11	Ammonium Glycyrrhizinate and Bergamot Essential Oil Co-Loaded Ultradeformable Nanocarriers: An Effective Natural Nanomedicine for In Vivo Anti-Inflammatory Topical Therapies 2022 ·Biomedicines ·Maria Chiara Cristiano, Nicola d’Avanzo, Antonia Mancuso, (unknown), Antonella Barone, Daniele Torella, Donatella Paolino, Massimo Fresta	17
12	Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy 2022 ·Biomedicines ·Antonella Barone, Nicola d’Avanzo, Maria Chiara Cristiano, Donatella Paolino, Massimo Fresta	21
13	Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis breakdown → 2022 ·ACS Nano ·(unknown), Maria Chiara Cristiano, Christian Celia, Nicola d’Avanzo, Antonia Mancuso, Donatella Paolino, Joy Wolfram, Massimo Fresta	106
14	Doxorubicin Hydrochloride-Loaded Nonionic Surfactant Vesicles to Treat Metastatic and Non-Metastatic Breast Cancer 2021 ·ACS Omega ·Martina Di Francesco, Christian Celia, Maria Chiara Cristiano, Nicola d’Avanzo, Barbara Ruozi, Constantin Mircioiu, Donato Cosco, Luisa Di Marzio, Massimo Fresta	39
15	Influence of Materials Properties on Bio-Physical Features and Effectiveness of 3D-Scaffolds for Periodontal Regeneration 2021 ·Molecules ·Nicola d’Avanzo, (unknown), Amerigo Giudice, Antonia Mancuso, Federica De Gaetano, Maria Chiara Cristiano, Donatella Paolino, Massimo Fresta	28
16	Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds 2021 ·Stem Cells International ·(unknown), Nicola d’Avanzo, Valentina Russo, Luisa Di Marzio, Felisa Cilurzo, Donatella Paolino, Massimo Fresta, Barbara Barboni, Hélder A. Santos, Christian Celia	20
17	LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy 2021 ·International Journal of Pharmaceutics ·Nicola d’Avanzo, Giulia Torrieri, Patrícia Figueiredo, Christian Celia, Donatella Paolino, Alexandra Correia, Karina Moslova, Tambet Teesalu, Massimo Fresta, Hélder A. Santos	74
18	Praziquantel-loaded calcite crystals: Synthesis, physicochemical characterization, and biopharmaceutical properties of inorganic biomaterials for drug delivery 2021 ·Journal of Drug Delivery Science and Technology ·Luisa Di Marzio, Ana Borrego‐Sánchez, (unknown), (unknown), Jaime Gómez‐Morales, Nicola d’Avanzo, C. Ignacio Sainz‐Díaz, Christian Celia, César Viseras	4
19	Nanoliposomes as Multidrug Carrier of Gemcitabine/Paclitaxel for the Effective Treatment of Metastatic Breast Cancer Disease: A Comparison with Gemzar and Taxol 2020 ·Advanced Therapeutics ·Christian Celia, Maria Chiara Cristiano, Francesca Froiio, Martina Di Francesco, Nicola d’Avanzo, Luisa Di Marzio, Massimo Fresta	24
20	Physicochemical characterization of pH-responsive and fusogenic self-assembled non-phospholipid vesicles for a potential multiple targeting therapy 2017 ·International Journal of Pharmaceutics ·Martina Di Francesco, Christian Celia, Rosita Primavera, Nicola d’Avanzo, Marcello Locatelli, Massimo Fresta, Felisa Cilurzo, Cinzia Anna Ventura, Donatella Paolino, Luisa Di Marzio	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact